4882 — Perseus Proteomics Cashflow Statement
0.000.00%
Last trade - 00:00- ¥8bn
- ¥7bn
- ¥100m
Annual cashflow statement for Perseus Proteomics, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -840 | -411 | -597 | -785 | -1,103 |
| Depreciation | |||||
| Non-Cash Items | 5.13 | 1.16 | 135 | 127 | 201 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 226 | -12.8 | -17.9 | 88.3 | 64.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -609 | -423 | -477 | -564 | -834 |
| Capital Expenditures | -2.61 | -2.82 | -33.9 | -171 | -159 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.803 | — | — | -42.4 | 8.63 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.41 | -2.82 | -33.9 | -213 | -150 |
| Financing Cash Flow Items | — | — | -4.87 | — | -0.097 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | — | 1,011 | 2,648 | -0.02 | 63.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -618 | 587 | 2,146 | -770 | -904 |